Is it safe to start aripiprazole (Abilify) 10 mg in a patient with serum sodium of 123 mmol/L (severe hyponatremia)?

Do Not Start Abilify 10 mg with Sodium of 123 mmol/L

You should not initiate aripiprazole (Abilify) 10 mg in a patient with a serum sodium of 123 mmol/L—this represents severe hyponatremia that requires urgent correction before starting any antipsychotic, particularly one that can further worsen hyponatremia.

Why This Is Unsafe

Aripiprazole Can Cause or Worsen Hyponatremia

While the FDA label for Abilify does not explicitly contraindicate use in hyponatremia 11, multiple case reports demonstrate that aripiprazole can induce SIADH and severe hyponatremia:

• A documented case showed a patient developing sodium of 108 mmol/L after aripiprazole dose increase, with recurrence to 118 mmol/L upon rechallenge 2
• Recent 2025 case report confirms aripiprazole-induced hyponatremia upon rechallenge, establishing causality 3
• Systematic review identified aripiprazole among second-generation antipsychotics associated with hyponatremia, with average nadir sodium of 112 mmol/L 4

However, one 2026 comparative study found aripiprazole had lower risk than olanzapine (adjusted HR 0.52) 5, suggesting it may be relatively safer among antipsychotics—but this does not make it safe to start in someone already severely hyponatremic.

Severe Hyponatremia (123 mmol/L) Requires Immediate Management

Your patient's sodium of 123 mmol/L falls into the severe hyponatremia category (< 125 mmol/L) 6:

• This level warrants hospitalization according to cirrhosis guidelines 6
• Risk of seizures, altered mental status, cardiopulmonary complications 6
• Starting a medication that can worsen hyponatremia could precipitate life-threatening complications

What You Should Do Instead

Step 1: Hospitalize and Correct the Hyponatremia First

Following guideline recommendations for severe hyponatremia 6:

• Admit the patient for monitoring and correction
• Discontinue or hold diuretics and laxatives if present
• Restrict fluids to less than urine output (typically 1-1.5 L/day)
• Evaluate for underlying causes: infection (including paracentesis if ascites present), thyroid/adrenal dysfunction, cardiac/renal disease, alcohol use, other medications
• Correct hypokalemia if present
• Target sodium > 125 mmol/L before considering antipsychotic initiation

Step 2: Consider Safer Alternatives or Delay Treatment

Once sodium is corrected to > 125-130 mmol/L:

• If aripiprazole is specifically needed, start at the lowest possible dose (2 mg/day per FDA label) 11
• Monitor sodium levels closely (every 2-3 days initially, then weekly)
• Consider whether the psychiatric indication is urgent enough to justify any antipsychotic, or if treatment can be delayed until sodium normalizes to > 135 mmol/L

Step 3: If Antipsychotic Is Urgently Needed

If you absolutely must start an antipsychotic before full correction:

• Wait until sodium is at least > 125 mmol/L (preferably > 130 mmol/L)
• Based on comparative data, aripiprazole may be relatively safer than olanzapine 5, but all antipsychotics carry risk 47
• Start at 2 mg/day (not 10 mg) and titrate slowly 11
• Monitor sodium every 2-3 days for the first 2 weeks
• Educate patient/caregivers about symptoms of worsening hyponatremia (confusion, nausea, headache, seizures)

Critical Pitfalls to Avoid

• Do not assume the hyponatremia is unrelated to future medication—adding aripiprazole could worsen it through SIADH 23
• Do not start at 10 mg—this is too high for someone with severe electrolyte disturbance; FDA label allows 2 mg starting dose 11
• Do not correct sodium too rapidly (> 8-10 mmol/L in 24 hours)—risk of osmotic demyelination syndrome 8
• Do not forget to monitor urine sodium and osmolality during correction to guide fluid management 6

The combination of thiazides and psychotropics significantly prolongs correction time 9, so if your patient is on diuretics, expect slower normalization and increased vigilance.